Volasertib is an extremely potent and selective inhibitor (IC50s: Plk1= 0.87 nM, Plk2 = 5 nM, Plk3 = 56 nM) of Polo-like kinase 1, a critical controller of multiple essential steps of mitosis.1 It has shown efficacy in multiple solid xenograft tumors mo
* VAT and and shipping costs not included. Errors and price changes excepted